Literature DB >> 28590053

Bryostatin and its synthetic analog, picolog rescue dermal fibroblasts from prolonged stress and contribute to survival and rejuvenation of human skin equivalents.

Tapan K Khan1, Paul A Wender2,3, Daniel L Alkon4.   

Abstract

Skin health is associated with the day-to-day activity of fibroblasts. The primary function of fibroblasts is to synthesize structural proteins, such as collagen, extracellular matrix proteins, and other proteins that support the structural integrity of the skin and are associated with younger, firmer, and more elastic skin that is better able to resist and recover from injury. At sub-nanomolar concentrations (0.03-0.3 nM), bryostatin-1 and its synthetic analog, picolog (0.1-10 nM) sustained the survival and activation of human dermal fibroblasts cultured under the stressful condition of prolonged serum deprivation. Bryostatin-1 treatment stabilized human skin equivalents (HSEs), a bioengineered combination of primary human skin cells (keratinocytes and dermal fibroblasts) on an extracellular matrix composed of mainly collagen. Fibroblasts activated by bryostatin-1 protected the structural integrity of HSEs. Bryostatin-1 and picolog prolonged activation of Erk in fibroblasts to promote cell survival. Chronic stress promotes the progression of apoptosis. Dermal fibroblasts constitutively express all components of Fas associated apoptosis, including caspase-8, an initiator enzyme of apoptosis. Prolong bryostatin-1 treatment reduced apoptosis by decreasing caspase-8 and protected dermal fibroblasts. Our data suggest that bryostatin-1 and picolog could be useful in anti-aging skincare, and could have applications in tissue engineering and regenerative medicine.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Erk; bryologue; bryostatin-1; caspase-8; dermal fibroblasts; human skin equivalent (HSE); keratinocytes; skin care

Mesh:

Substances:

Year:  2017        PMID: 28590053      PMCID: PMC5673504          DOI: 10.1002/jcp.26043

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  29 in total

1.  Serial cultivation of normal human keratinocytes: a defined system for studying the regulation of growth and differentiation.

Authors:  E W Johnson; S F Meunier; C J Roy; N L Parenteau
Journal:  In Vitro Cell Dev Biol       Date:  1992-06

2.  An in vitro model for identifying skin-corrosive chemicals. I. Initial validation.

Authors:  G J Oliver; M A Pemberton; C Rhodes
Journal:  Toxicol In Vitro       Date:  1988       Impact factor: 3.500

3.  The EpiSkin phototoxicity assay (EPA): development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency.

Authors:  Damien Lelièvre; Pascale Justine; François Christiaens; Nicole Bonaventure; Julie Coutet; Laurent Marrot; José Cotovio
Journal:  Toxicol In Vitro       Date:  2007-05-01       Impact factor: 3.500

Review 4.  A review of tissue-engineered skin bioconstructs available for skin reconstruction.

Authors:  Rostislav V Shevchenko; Stuart L James; S Elizabeth James
Journal:  J R Soc Interface       Date:  2009-10-28       Impact factor: 4.118

5.  H2O2 accumulation by catalase reduction changes MAP kinase signaling in aged human skin in vivo.

Authors:  Mi Hee Shin; Gi-eun Rhie; Yeon Kyung Kim; Chi-Hyun Park; Kwang Hyun Cho; Kyu Han Kim; Hee Chul Eun; Jin Ho Chung
Journal:  J Invest Dermatol       Date:  2005-08       Impact factor: 8.551

Review 6.  Photodynamic therapy enhancement of anti-tumor immunity.

Authors:  Craig M Brackett; Sandra O Gollnick
Journal:  Photochem Photobiol Sci       Date:  2011-01-21       Impact factor: 3.982

7.  Poststroke neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in adult brains.

Authors:  Miao-Kun Sun; Jarin Hongpaisan; Thomas J Nelson; Daniel L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

8.  Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice.

Authors:  René Etcheberrigaray; Mathew Tan; Ilse Dewachter; Cuno Kuipéri; Ingrid Van der Auwera; Stefaan Wera; Lixin Qiao; Barry Bank; Thomas J Nelson; Alan P Kozikowski; Fred Van Leuven; Daniel L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

9.  Bryostatin-1 vs. TPPB: dose-dependent APP processing and PKC-α, -δ, and -ε isoform activation in SH-SY5Y neuronal cells.

Authors:  P Yi; L Schrott; T P Castor; J S Alexander
Journal:  J Mol Neurosci       Date:  2012-06-15       Impact factor: 3.444

10.  Targeting caspase-6 and caspase-8 to promote neuronal survival following ischemic stroke.

Authors:  A P Shabanzadeh; P M D'Onofrio; P P Monnier; P D Koeberle
Journal:  Cell Death Dis       Date:  2015-11-05       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.